Methylmercury-Induced Inhibition of Paraoxonase-1 (PON1)—Implications for Cardiovascular Risk

Author：

ISSN： 1087-2620

Source： Journal of Toxicology and Environmental Health, Vol.77, Iss.17, 2014-09, pp. : 1004-1023

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme

Current Clinical Pharmacology, Vol. 11, Iss. 4, 2016-12 ,pp. : 259-264

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphism in Paraoxonase 1 (PON1): Population Distribution of PON1 Activity

By Ginsberg Gary

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 473-507

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Role of Paraoxonase 1 Activity in Cardiovascular Disease: Potential for Therapeutic Intervention

By Michael I. Mackness Paul N. Durrington Bharti Mackness

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 4, 2004-01 ,pp. : 211-217

Adis International

Access to resources Recommend Favorite

Targeting paraoxonase-1 in atherosclerosis

By Mackness Mike Mackness Bharti

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 829-837

Informa Healthcare

Access to resources Recommend Favorite

Rapid Progress on the Clopidogrel PON1 Story

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 41, Iss. 4, 2011-12 ,pp. : 258-259

John Wiley & Sons Inc

Access to resources Recommend Favorite